Correlation between work productivity loss and EORTC QLQ-C30 and -BR23 domains from the MONALEESA-7 trial of premenopausal women with HR+/HER2− advanced breast cancer

Background: The phase III MONALEESA-7 trial (NCT02278120) assessed ribociclib + endocrine therapy (ET) versus ET in premenopausal women with HR+/HER2− advanced breast cancer (ABC). The relationship between work productivity loss (WPL) and domains of European Organisation for Research and Treatment o...

Descrición completa

Detalles Bibliográficos

Principais autores:	Debu Tripathy, Tristan Curteis, Sara Hurvitz, Denise Yardley, Fabio Franke, K. Govind Babu, Paul Wheatley-Price, Young-Hyuck Im, Radost Pencheva, Lucy A. Eddowes, Pierre-Alexandre Dionne, David Chandiwana, Purnima Pathak, Brad Lanoue, Nadia Harbeck
Formato:	Artigo
Idioma:	Inglês
Publicado:	SAGE Publishing 2022-02-01
Series:	Therapeutic Advances in Medical Oncology
Acceso en liña:	https://doi.org/10.1177/17588359221081203
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!